120 related articles for article (PubMed ID: 26778756)
1. (125)I interstitial brachytherapy for the treatment of myoepithelial carcinoma of the oral and maxillofacial region.
Zheng L; Lv X; Shi Y; Zhang Y; Yu G; Zhang J
Brachytherapy; 2016; 15(2):240-5. PubMed ID: 26778756
[TBL] [Abstract][Full Text] [Related]
2. 125I brachytherapy alone for recurrent or locally advanced adenoid cystic carcinoma of the oral and maxillofacial region.
Huang MW; Zheng L; Liu SM; Shi Y; Zhang J; Yu GY; Zhang JG
Strahlenther Onkol; 2013 Jun; 189(6):502-7. PubMed ID: 23625361
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of (125)I interstitial brachytherapy for locally recurrent parotid gland cancer in previously irradiated patients.
Zheng L; Zhang J; Zhang J; Song T; Huang M; Yu G
Head Neck; 2012 Oct; 34(10):1445-9. PubMed ID: 22488812
[TBL] [Abstract][Full Text] [Related]
4. The role of
Huang MW; Wu WJ; Lv XM; Yu GY; Zhang JG
Brachytherapy; 2018; 17(1):244-249. PubMed ID: 29102739
[TBL] [Abstract][Full Text] [Related]
5. Iodine-125 brachytherapy for the treatment of a large parotid epithelial-myoepithelial carcinoma in a child.
Zhang J; Zhen L; Zhang JG; Yu GY
Int J Oral Maxillofac Surg; 2014 Dec; 43(12):1431-5. PubMed ID: 25240907
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy for recurrent malignant tumours of the parotid gland.
Zhang J; Zheng L; Liu SM; Huang MW; Shi Y; Wang W; Zhang JG
Br J Oral Maxillofac Surg; 2015 Jan; 53(1):58-62. PubMed ID: 25445387
[TBL] [Abstract][Full Text] [Related]
7. Postoperative [¹²⁵I] seed brachytherapy in the treatment of acinic cell carcinoma of the parotid gland: with associated risk factors.
Mao MH; Zhang JG; Zhang J; Zheng L; Liu SM; Huang MW; Shi Y
Strahlenther Onkol; 2014 Oct; 190(11):1008-14. PubMed ID: 24781865
[TBL] [Abstract][Full Text] [Related]
8. [125I seed implant brachytherapy of recurrent parotid gland malignant tumor].
Zhang J; Zhang JG; Cai ZG; Zhang Y; Huang MX; Yu GY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Jan; 44(1):2-4. PubMed ID: 19489249
[TBL] [Abstract][Full Text] [Related]
9. Mandibular growth in survivors of pediatric parotid gland carcinoma treated with interstitial brachytherapy.
Wu WJ; Huang MW; Zhang GH; Zhao D; Zheng L; Yu GY; Zhang JG
Pediatr Blood Cancer; 2018 Sep; 65(9):e27223. PubMed ID: 29797637
[TBL] [Abstract][Full Text] [Related]
10. TPS-guided interstitial Iodine-125 implantation in patients with oral cavity and maxillofacial carcinomas.
Meng J; Zhang J; Zhuang QW; Wang X; Li ZP; Gu QP
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2803-7. PubMed ID: 25339473
[TBL] [Abstract][Full Text] [Related]
11. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
12.
Chen P; Wu WJ; Yi ZQ; Ma XL; Zhao WH; Zhang JG
Pediatr Blood Cancer; 2019 May; 66(5):e27622. PubMed ID: 30666774
[TBL] [Abstract][Full Text] [Related]
13. Locally Advanced Malignant Myoepithelioma of the Parotid Gland Treated With Radiotherapy: A Case Study and Review of the BC Cancer Agency Experience.
Caon J; Alexander C; Kader HA
Am J Clin Oncol; 2017 Jun; 40(3):318-322. PubMed ID: 25503425
[TBL] [Abstract][Full Text] [Related]
14. Iodine-125 brachytherapy in the management of squamous cell carcinoma of the oral cavity and oropharynx.
Stannard C; Maree G; Tovey S; Hunter A; Wetter J
Brachytherapy; 2014; 13(4):405-12. PubMed ID: 24818781
[TBL] [Abstract][Full Text] [Related]
15. Iodine-125 brachytherapy alone for advanced primary parotid gland carcinoma.
Zhou C; Zhang J; Zhang JG; Liu SM; Zheng L; Huang MW; Shi Y; Lv XM
Int J Oral Maxillofac Surg; 2018 May; 47(5):561-567. PubMed ID: 28966067
[TBL] [Abstract][Full Text] [Related]
16. Postoperative iodine-125 interstitial brachytherapy for the early stages of minor salivary gland carcinomas of the lip and buccal mucosa with positive or close margins.
Wu WJ; Shao X; Huang MW; Lv XM; Zhang XN; Zhang JG
Head Neck; 2017 Mar; 39(3):572-577. PubMed ID: 28075511
[TBL] [Abstract][Full Text] [Related]
17. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
Strnad V; Geiger M; Lotter M; Sauer R
Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
[TBL] [Abstract][Full Text] [Related]
18. Recurrent epithelial-myoepithelial carcinoma of the parotid with direct intracranial extension.
Amin KS; McGuff HS; Cashman SW; Newman R
Otolaryngol Head Neck Surg; 2002 Jan; 126(1):83-4. PubMed ID: 11821774
[No Abstract] [Full Text] [Related]
19. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
[TBL] [Abstract][Full Text] [Related]
20. [
Yu HB; Wu WJ; Lv XM; Shi Y; Zheng L; Zhang JG
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):919-923. PubMed ID: 33047730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
